Annual EBIT:
-$145.59M-$31.42M(-27.52%)Summary
- As of today, TNGX annual earnings before interest & taxes is -$145.59 million, with the most recent change of -$31.42 million (-27.52%) on December 31, 2024.
- During the last 3 years, TNGX annual EBIT has fallen by -$87.41 million (-150.21%).
- TNGX annual EBIT is now -178.92% below its all-time high of -$52.20 million, reached on December 31, 2020.
Performance
TNGX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$14.07M+$55.04M(+134.35%)Summary
- As of today, TNGX quarterly earnings before interest & taxes is $14.07 million, with the most recent change of +$55.04 million (+134.35%) on September 30, 2025.
- Over the past year, TNGX quarterly EBIT has increased by +$46.95 million (+142.80%).
- TNGX quarterly EBIT is now at all-time high.
Performance
TNGX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$110.33M+$46.95M(+29.85%)Summary
- As of today, TNGX TTM earnings before interest & taxes is -$110.33 million, with the most recent change of +$46.95 million (+29.85%) on September 30, 2025.
- Over the past year, TNGX TTM EBIT has increased by +$29.36 million (+21.02%).
- TNGX TTM EBIT is now -22066900.00% below its all-time high of -$500.00, reached on June 30, 2020.
Performance
TNGX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TNGX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -27.5% | +142.8% | +21.0% |
| 3Y3 Years | -150.2% | +147.0% | -7.7% |
| 5Y5 Years | -178.9% | +152.6% | -312.4% |
TNGX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -150.2% | at low | at high | +133.1% | -7.7% | +29.9% |
| 5Y | 5-Year | -178.9% | at low | at high | +133.1% | -312.4% | +29.9% |
| All-Time | All-Time | -178.9% | at low | at high | +133.1% | >-9999.0% | +29.9% |
TNGX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $14.07M(+134.3%) | -$110.33M(+29.9%) |
| Jun 2025 | - | -$40.97M(+3.7%) | -$157.28M(-7.8%) |
| Mar 2025 | - | -$42.53M(-4.0%) | -$145.87M(-0.2%) |
| Dec 2024 | -$145.59M(-27.5%) | -$40.91M(-24.4%) | -$145.59M(-4.2%) |
| Sep 2024 | - | -$32.88M(-11.3%) | -$139.70M(-5.5%) |
| Jun 2024 | - | -$29.55M(+30.1%) | -$132.45M(-5.0%) |
| Mar 2024 | - | -$42.26M(-20.7%) | -$126.14M(-10.5%) |
| Dec 2023 | -$114.17M(-2.8%) | -$35.01M(-36.6%) | -$114.17M(-4.1%) |
| Sep 2023 | - | -$25.63M(-10.2%) | -$109.73M(+3.8%) |
| Jun 2023 | - | -$23.25M(+23.2%) | -$114.02M(+1.7%) |
| Mar 2023 | - | -$30.29M(+0.9%) | -$115.98M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$111.07M(-90.9%) | -$30.57M(-2.2%) | -$111.07M(-8.4%) |
| Sep 2022 | - | -$29.92M(-18.7%) | -$102.49M(-11.2%) |
| Jun 2022 | - | -$25.20M(+0.7%) | -$92.13M(-28.9%) |
| Mar 2022 | - | -$25.38M(-15.4%) | -$71.49M(-22.9%) |
| Dec 2021 | -$58.19M(-11.5%) | -$21.98M(-12.3%) | -$58.19M(-28.9%) |
| Sep 2021 | - | -$19.57M(-329.5%) | -$45.14M(+13.7%) |
| Jun 2021 | - | -$4.56M(+62.3%) | -$52.33M(-9.5%) |
| Mar 2021 | - | -$12.08M(-35.2%) | -$47.78M(-33.8%) |
| Dec 2020 | -$52.20M | -$8.94M(+66.6%) | -$35.69M(-33.4%) |
| Sep 2020 | - | -$26.76M(>-9900.0%) | -$26.76M(>-9900.0%) |
| Jun 2020 | - | -$500.00 | -$500.00 |
FAQ
- What is Tango Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. annual EBIT year-on-year change?
- What is Tango Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Tango Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. TTM EBIT year-on-year change?
What is Tango Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of TNGX is -$145.59M
What is the all-time high annual EBIT for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$52.20M
What is Tango Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, TNGX annual earnings before interest & taxes has changed by -$31.42M (-27.52%)
What is Tango Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TNGX is $14.07M
What is the all-time high quarterly EBIT for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $14.07M
What is Tango Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, TNGX quarterly earnings before interest & taxes has changed by +$46.95M (+142.80%)
What is Tango Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TNGX is -$110.33M
What is the all-time high TTM EBIT for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$500.00
What is Tango Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, TNGX TTM earnings before interest & taxes has changed by +$29.36M (+21.02%)